Tesamorelin is a synthetic form of growth-hormone-releasing hormone which is used in the treatment of HIV-associated lipodystrophy, approved initially in 2010.
CAT No: HB00122
CAS No:218949-48-5 / 901758-09-6
Synonyms/Alias:Egrifta;Tesamorelin;218949-48-5;804475-66-9;TH9507;TH 9507;TH-9507;UNII-MQG94M5EEO;Tesamorelin [USAN:INN];MQG94M5EEO;(3E)-hex-3-enoylsomatoliberin;GTPL6959;DTXSID00583207;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.